Investigation of Association between TLR9 Gene Polymorphisms and VKH in Japanese Patients

REFERENCES

• Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995;39(4):265–292.
   Google Scholar
• Islam SM, Nugama J, Fujino Y, et al. Relation between the clinical course of Vogt-Koyanagi-Harada’s disease and human leukocyte antigen (HLA)-DR4 subtypes. Nippon Ganka Gakkai Zasshi. 1994; 98:797–801.
   PubMedGoogle Scholar
• Shindo Y, Inoko H, Yamamoto T, et al. HLA-DRB1 typing of VKH disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410. Br J Ophthalmol. 1994; 78:223–226.
   PubMed Web of Science ®Google Scholar
• Damico FM, Cunha-Neto E, Goldberg AC, et al. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and−negative Vogt-Koyanagi Harada uveitis. Invest Ophthalmol Vis Sci. 2005; 46;2465–2471.
   PubMed Web of Science ®Google Scholar
• Andreoli CM, Foster CS. Vogt-Koyanagi-Harada disease. Int Ophtalmol Clin. 2006; 46:111–122.
   PubMedGoogle Scholar
• Kim MH, Seong MC, Kwa NH, et al. Association of HLA with Vogt-Koyanagi-Harada syndrome in Koreans. Am J Ophtalmol. 2007; 15: 89–97.
   Google Scholar
• Norose K, Yano A. Melanoma specific Th1 cytotoxic T lymphocyte line in Vogt-Koyanagi-Harada disease. Br J Ophtalmol. 1996; 80:10002–8.
   Google Scholar
• Sugita S, Takase H, Taguchi C, et al. Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens. Invest Ophthalmol Vis Sci. 2006; 47:2547–2554.
   PubMed Web of Science ®Google Scholar
• Chi W, Yang P, Li B, et al. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol. 2007; 119:1218–1224.
   PubMed Web of Science ®Google Scholar
• Chen L, Yang P, Zhou H, et al. Diminished frequency and function of CD4+D25 high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome. Invest Ophthalmol Vis Sci. 2008; 49:3475–3482.
   PubMed Web of Science ®Google Scholar
• Maezawa N, Yano A, Taniguchi M, Kojima S. The role of cytotoxic T lymphocytes in the pathogenesis of Vogt-Koyanagi-Harada disease. Ophthalmologica. 1982;185(3):179–186.
   Google Scholar
• Minoda H, Sakai J, Sugiura M, Imai S, Osato T, Usui M. Nippon Ganka Gakkai Zasshi: high inducibility of Epstein-Barr virus replication in B lymphocytes in Vogt-Koyanagi-Harada disease. Nippon Ganka Gakkai Zasshi. 1999;103(4):289–296.
   Google Scholar
• Sugita S, Takase H, Kawaguchi T, Taguchi C, Mochizuki M. Cross-reaction between tyrosinase peptides and cytomegalovirus antigen by T cells from patients with Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2007 Apr-Jun;27(2-3):87–95.
   Google Scholar
• Ito T, Wang YH, Liu YJ. Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR 7) and TLR9. Springer Semin Immunopathol. 2005;26: 221–229.
   PubMed Web of Science ®Google Scholar
• Sato A, Linehan MM, Iwasaki A. Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc Natl Acad Sci U S A. 2006; 103: 17343–17348.
   PubMed Web of Science ®Google Scholar
• Lazarus R, Klimecki WT, Raby BA, Vercelli D, et al. Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR): frequencies, pairwise linkage disequilibrium, and haplotypes in three US, ethnic groups and exploratory case-control disease association studies. Genomics. 2003; 81:85–91.
   PubMed Web of Science ®Google Scholar
• Török HP, Glas J, Tonenchi L, Bruennler G, et al. Crohn’s disease is associated with a toll-like receptor-9 polymorphism. Gastroenterology. 2004; 127: 365–366.
   PubMed Web of Science ®Google Scholar
• Hur JW, Shin HD, Park BL, Kim LH, et al. Association study of Toll-like receptor 9 gene polymorphism in Korean patients with systemic lupus erythematosus. Tissue Antigens. 2005; 65: 266–270.
   PubMed Web of Science ®Google Scholar
• Veltkamp M, van Moorsel CHM, Rijkers GT, et al. Toll-like receptor (TLR)-9 genetics and function in sarcoidosis. Clin Exp Immunol. 2010; 162:68–74.
   Google Scholar
• Ito A, Ota M, Katsuyama Y, Inoko H, et al. Lack of association of Toll-like receptor 9 gene polymorphism with Behçet’s disease in Japanese patients. Tissue Antigens. 2007; 70: 423–426.
   Google Scholar
• Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005; 21(2):263–265.
   PubMed Web of Science ®Google Scholar
• Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science. 2002; 296(5576):2225–2229.
   PubMed Web of Science ®Google Scholar
• Qin Z, Niu T, Liu J. Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am J Hum Genet. 2002; 71(5):1242–1247.
   Google Scholar
• Bauer S, Hacker KC, Redecke H, Hausmann S, et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci U S A. 2001; 98:9237–9242.
   PubMed Web of Science ®Google Scholar
• Kindrachuk J, Potter JE, Brownlie R, et al. Nucleic acids exert a sequence-independent cooperative effect on sequence-dependent activation of toll-like receptor 9. J Biol Chem. 2007; 282: 13944–13953.
   PubMed Web of Science ®Google Scholar
• Minns LA, Menard LC, Foureau DM, et al. TLR9 is required for the gut-associated lymphoid tissue response following oral infection of toxoplasma gondii. J Immunol. 2006; 176:7589–7597.
   Google Scholar
• Takaoka A, Yanai H, Kondo S, et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature. 2005;434:243–249.
   PubMed Web of Science ®Google Scholar
• Bassili SS, Peyman GA, Gebhardt BM, et al. Detection of Epstein-Barr virus DNA by polymerase chain reaction in the vitreous from a patient with Vogt-Koyanagi-Harada syndrome. Retina. 1996; 16:160–161.
   PubMed Web of Science ®Google Scholar